While not necessarily seen as a game changer, the drug is seen as likely to become a first-line standard of care for Covid-19 given the lack of approved treatments. The EUA follows positive data from an NIH-sponsored trial that were announced earlier this week.

LEAVE A REPLY

Please enter your comment!
Please enter your name here